2024-10-01 2025-09-30 false Capium Accounts Production 1.1 15153938 2024-10-01 2025-09-30 15153938 bus:FullAccounts 2024-10-01 2025-09-30 15153938 bus:FRS102 2024-10-01 2025-09-30 15153938 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 15153938 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 15153938 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 15153938 2024-10-01 2025-09-30 15153938 2025-09-30 15153938 bus:RegisteredOffice 2024-10-01 2025-09-30 15153938 core:WithinOneYear 2025-09-30 15153938 core:AfterOneYear 2025-09-30 15153938 1 2024-10-01 2025-09-30 15153938 bus:Director1 2024-10-01 2025-09-30 15153938 bus:Director1 2025-09-30 15153938 bus:Director1 2023-09-21 2024-09-30 15153938 2023-09-21 15153938 bus:LeadAgentIfApplicable 2024-10-01 2025-09-30 15153938 2023-09-21 2024-09-30 15153938 2024-09-30 15153938 core:WithinOneYear 2024-09-30 15153938 core:AfterOneYear 2024-09-30 15153938 bus:EntityAccountantsOrAuditors 2023-09-21 2024-09-30 15153938 bus:OrdinaryShareClass1 2024-10-01 2025-09-30 15153938 bus:OrdinaryShareClass1 2025-09-30 15153938 bus:OrdinaryShareClass1 2023-09-21 2024-09-30 15153938 bus:OrdinaryShareClass1 2024-09-30 15153938 core:CostValuation core:Non-currentFinancialInstruments 2025-09-30 15153938 core:CostValuation core:Non-currentFinancialInstruments 2024-09-30 15153938 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-09-30 15153938 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 15153938 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-09-30 15153938 core:Non-currentFinancialInstruments 2025-09-30 15153938 core:Non-currentFinancialInstruments 2024-09-30 15153938 core:RetainedEarningsAccumulatedLosses 2025-09-30 15153938 core:RetainedEarningsAccumulatedLosses 2024-09-30 15153938 dpl:Item1 2024-10-01 15153938 dpl:Item1 2025-09-30 15153938 dpl:Item1 2023-09-21 15153938 dpl:Item1 2024-09-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 15153938
England and Wales

 

 

 

PHARMATECK LIMITED



Unaudited Financial Statements
 


Period of accounts

Start date: 01 October 2024

End date: 30 September 2025
Director Syed Raqeeb ul hassan Shah
Registered Number 15153938
Registered Office 25 Manor Gardens
Gateshead
NE10 8TB
Accountants Acumen Accounting
364 West Road
Newcastle Upon Tyne
Tyne & Wear
NE4 9JY
1
 
 
Notes
 
2025
£
  2024
£
Current assets      
Debtors 1,945    1,915 
Cash at bank and in hand 1,201    1,529 
3,146    3,444 
Creditors: amount falling due within one year (2,853)   (3,251)
Net current assets 293    193 
 
Total assets less current liabilities 293    193 
Net assets 293    193 
 

Capital and reserves
     
Profit and loss account 293    193 
Shareholders' funds 293    193 
 


For the year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 23 June 2026 and were signed by:


-------------------------------
Syed Raqeeb ul hassan Shah
Director
2
General Information
PHARMATECK LIMITED is a private company, limited by shares, registered in England and Wales, registration number 15153938, registration address 25 Manor Gardens, Gateshead, NE10 8TB.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
2.

Average number of employees

Average number of employees during the year was 1 (2024 : 1).
3